Last reviewed · How we verify
NCT06788496: ABBA-vention
Art-based Beauty Appreciation Intervention
NA trial testing Art-based Beauty Appreciation Intervention Program (Learning to See Beauty) in Young Adults in 114 participants. Completed in 18 July 2025.
18 July 2025
Quick facts
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 114 |
| Start date | 22 November 2024 |
| Primary completion | 18 July 2025 |
| Estimated completion | 18 July 2025 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Art-based Beauty Appreciation Intervention Program (Learning to See Beauty)
- Observation Program (Learning to Observe Life)
Conditions studied
- Young Adults — all drugs for Young Adults →
- Sensory Processing Sensitivity — all drugs for Sensory Processing Sensitivity →
Sponsor
Radboud University Medical Center
Who can join
Adults 18 to 28, any sex, with Young Adults or Sensory Processing Sensitivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized controlled trial with an active control condition evaluating the impact of an art-based beauty appreciation (ABBA) intervention on trait appreciation of beauty as a primary outcome and well-being and psychological distress as secondary outcomes. The central hypothesis is that the primary and secondary outcomes will increase more in the intervention than in the control condition.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Art-based beauty appreciation intervention in young adults: protocol for a two-arm active control mixed-method randomised controlled trial (ABBA-Vention).
Trupp MD, Igdalova A, Wijnands M, Spee BTM, et al · · 2026 · PMID 41736139 · DOI 10.1186/s13063-026-09563-0
Verify or expand the search:
- PubMed search for NCT06788496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Young Adults
Currently open trials in the same condition.
- NCT07235267 — Reliability and Validity of Tele-Assessment for Functional Performance in Older vs. Younger Adults · recruiting
- NCT06810271 — Walk It Off! the Influence of Physical Activity Level on the Recovery from Damaging Resistance Exercise · NA · active not recruiting
- NCT06385457 — The Effects of Mindhelper.dk: a Self-guided Digital Mental Health Promotion Service Targeting Young People · NA · recruiting
Other Radboud University Medical Center trials
Trials by the same sponsor.
- NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
- NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
- NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
- NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
- NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06788496 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
- Last refreshed: 17 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06788496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing